Please login to the form below
Digital intelligence blog
Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools
Novartis launches YouTube cancer talk show
Each Voice Counts forms part of firm’s existing advanced breast cancer initiative
Novartis is using YouTube to broadcast a new talk show about advanced breast cancer as part of its ongoing disease awareness efforts in the area.
The first episode of its Each Voice Counts talk show series features four women sharing their stories of life with the condition.
Novartis' key product in the area is Afinitor (everolimus), which gained European approval for advanced breast cancer in July, just days after US regulators passed it for the same indication.
The Each Voice Counts talk show follows the re-launch last week of Novartis' global AdvancedBreastCancerCommunity.org website.
The website is a collaboration between Novartis and Inspire, which builds and manages online support communities for patients and carers.
Advanced Breast Cancer Community offers a 'clearing house' of tailored information, covering topics such as creating a personal care plan and metastasis and recurrence.
Novartis' use of YouTube for videos in a talk show format, though unusual, is not unique, and has echoes of the Johnson & Johnson's employee video series ennTV, which debuted in April and the New Way RA talk show it began in 2009.
Featured jobs
- Publications Director, Medical Communications agency, Oxford
-
Competitive Salary
- Publications Director, Medical Communications agency, Home Based...
-
Competitive Salary
- Client Partner, Healthcare Brand Communications, London
-
Highly competitive package
- Strategic Associate Director Healthcare PR, London
-
Substantiel package
- Account Director, Healthcare Communications
-
Salary TBC
- Publications Director, Medical Communications agency, Cambridge
-
Competitive Salary
Subscribe to our email news alerts
- Boehringer taps Korea’s Bridge for Ofev follow-up
- Pear Therapeutics submits latest digital therapeutic, insomnia and depression treatment
- Novartis and J&J back latest €400m Medicxi biopharma fund
- How To Get To A Great Culture by Dave Birss
- Episode 2: Alder Play - Cameron Day (ustwo)
- Episode 1: Patient Centricity on Trial - Claire Knapp and Mark Evans, Havas Lynx Group, Keynote
PMHub
Nobull Communications
Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...
Latest intelligence
- Precision paediatrics: Treating patients with CAR-T
- Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
- What does it mean to be an agile organisation
- We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
- Battling breast cancer with precision medicine (Part 2)
- Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...
Quick links
Infographics
